Correlation Between Seres Therapeutics and Elevai Labs,

Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Elevai Labs, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Elevai Labs, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Seres Therapeutics and Elevai Labs, Common, you can compare the effects of market volatilities on Seres Therapeutics and Elevai Labs, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Elevai Labs,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Elevai Labs,.

Diversification Opportunities for Seres Therapeutics and Elevai Labs,

-0.24

Correlation Coefficient

Seres Therapeutics  Elevai Labs,

Very good diversification

The 3 months correlation between Seres and Elevai is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Elevai Labs, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevai Labs, Common and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Elevai Labs,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevai Labs, Common has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Elevai Labs, go up and down completely randomly.

Pair Corralation between Seres Therapeutics and Elevai Labs,

Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Elevai Labs,. But the stock apears to be less risky and, when comparing its historical volatility, Seres Therapeutics is 1.4 times less risky than Elevai Labs,. The stock trades about -0.33 of its potential returns per unit of risk. The Elevai Labs, Common is currently generating about -0.19 of returns per unit of risk over similar time horizon. If you would invest  261.00  in Elevai Labs, Common on October 23, 2024 and sell it today you would lose (49.00) from holding Elevai Labs, Common or give up 18.77% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	94.74%
Values	Daily Returns

Seres Therapeutics  vs.  Elevai Labs, Common

Seres Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Seres Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Elevai Labs, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Elevai Labs, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Seres Therapeutics and Elevai Labs,

The main advantage of trading using opposite Seres Therapeutics and Elevai Labs, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Elevai Labs, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevai Labs, will offset losses from the drop in Elevai Labs,'s long position.

The idea behind Seres Therapeutics and Elevai Labs, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.